Pura Vida Investments’s Novartis NVS Stock Holding History

Pura Vida Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-102,812	Closed	-$7.27M	–	82
2016 Q3	$7.27M	Buy	+102,812	New	+$7.49M	2.21%	13

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Pura Vida Investments's NVS Position: Q4 2016 in Review

Pura Vida Investments sold out of Novartis (NVS) in Q4 2016, closing a stake of 102,812 shares — an estimated $7.27M sold.

Pura Vida Investments first reported a position in NVS in Q3 2016 and held it in 1 quarter. The position peaked at $7.27M in Q3 2016. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Pura Vida Investments reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
Pura Vida Investments sold 102,812 Novartis shares in Q4 2016, an estimated $7.27M.
Pura Vida Investments first reported a position in Novartis in Q3 2016 and held it in 1 quarter.
Pura Vida Investments's Novartis position peaked at $7.27M in Q3 2016.
905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Pura Vida Investments's 13F filing for Q4 2016, filed 14 Feb 2017.